Biotech pain continues as Versant, MPM gene therapy startup calls it quits

A gene therapy startup backed by two key biopharmas and two premier biotech VC firms has ceased operations.

California biotech Coda Biotherapeutics shut down recently, investors Versant Ventures and MPM Capital confirmed to Endpoints News Tuesday night, declining to provide further details. The upstart had presented...

Click to view original post